Previous 10 | Next 10 |
Arcadia Biosciences (NASDAQ: RKDA ) +62% on USDA OK of drought-tolerant soybean strain. More news on: Arcadia Biosciences, Inc., Puma Biotechnology, Inc., Callaway Golf Company, Stocks on the move, Read more ...
Rhythm Pharmaceuticals (NASDAQ: RYTM ) +29% on positive late-stage setmelanotide data . More news on: Rhythm Pharmaceuticals, Inc., Guardant Health, Inc., Weight Watchers International, Inc., Stocks on the move, Read more ...
TherapeuticsMD, Inc. (TXMD) Q2 2019 Earnings Conference Call August 06, 2019 4:30 PM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Robert Finizio - Chief Executive Officer Daniel Cartwright - Chief Financial Officer Dawn Halkuff - Chief Commercia...
The following slide deck was published by TherapeuticsMD, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Therapeutics MD (NASDAQ: TXMD ): Q2 GAAP EPS of -$0.23 misses by $0.06 . More news on: TherapeuticsMD, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
IMVEXXY ® Net Revenue $3.1 Million for the Second Quarter of 2019 Total Net Revenue for the Second Quarter of 2019 Above Guidance at $6.1 Million Company Raises Full-Year Net Revenue Guidance to Range of $29.45 Million to $34.20 Million Conference Call Scheduled for 4:30 p.m. ...
ACLS , ADT , AFG , OTC:AINV , AIZ , AKCA , AMN , ANDE , APEI , AVD , AXGN , BECN , BNFT , BOLD , BTG , CARG , CMP , CPE , CPSI , CTRE , CUB , DCP , DHT , DIS , DVN , DXPE , EDIT , ENLC , ENTA , EVH , EVRI , FANG , FATE , FLT , FTR , GCP , GH , GTES , H...
Executive Management to Host Conference Call on August 6, 2019 at 4:30 p.m. ET TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its second quarter 2019 financial results on Tuesday, August 6, 2019, after the closing...
Editor's note: Seeking Alpha is proud to welcome Boston Biotech Investor as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » In my 3...
Initially, TheraupeticsMD ( TXMD ) was more of a trading idea than an investment as I was bullish on approval for Imvexxy and Bijuva. My trading thesis at that time was no additional trial was required for Imvexxy and Bijuva would be approved with no hiccup. The thesis was validated, but I...
News, Short Squeeze, Breakout and More Instantly...
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...